TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
2.970
+0.040 (1.37%)
At close: Dec 20, 2024, 4:00 PM
3.040
+0.070 (2.36%)
After-hours: Dec 20, 2024, 4:37 PM EST
TScan Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 168 | 279 | 37 | 107 | - | - |
| Market Cap Growth | 115.50% | 647.03% | -65.09% | - | - | - |
| Enterprise Value | -13 | 150 | -66 | -69 | - | - |
| Last Close Price | 2.97 | 5.83 | 1.55 | 4.50 | - | - |
| PS Ratio | 16.93 | 13.25 | 2.76 | 10.54 | - | - |
| PB Ratio | 0.69 | 1.85 | 0.38 | 0.67 | - | - |
| P/TBV Ratio | 1.15 | 1.85 | 0.38 | 0.67 | - | - |
| EV/Sales Ratio | 6.11 | 7.14 | - | - | - | - |
| Debt / Equity Ratio | 0.39 | 0.61 | 0.86 | 0.04 | 0.43 | 0.11 |
| Asset Turnover | 0.03 | 0.09 | 0.07 | 0.09 | 0.02 | - |
| Quick Ratio | 9.46 | 6.44 | 6.94 | 7.56 | 1.99 | 17.43 |
| Current Ratio | 9.56 | 6.51 | 7.17 | 7.76 | 2.09 | 17.69 |
| Return on Equity (ROE) | -55.92% | -71.29% | -50.90% | -54.64% | -87.44% | - |
| Return on Assets (ROA) | -23.35% | -24.79% | -21.51% | -25.56% | -33.08% | - |
| Return on Capital (ROIC) | -25.95% | -27.25% | -23.65% | -31.75% | -45.49% | - |
| Earnings Yield | -66.32% | -32.00% | -177.43% | -45.48% | - | - |
| FCF Yield | -65.89% | -23.13% | -189.50% | -54.82% | - | - |
| Buyback Yield / Dilution | -11.57% | -98.89% | -106.20% | -1173.20% | -137.87% | - |
| Total Shareholder Return | -11.57% | -98.89% | -106.20% | -1173.20% | -137.87% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.